Royalty Report: Medical, Delivery, Pain – Collection: 259017

$100.00

Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 3

Primary Industries

  • Medical
  • Delivery
  • Pain
  • Therapeutic
  • Device

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 259017

License Grant
The parties hereto have determined pursuant to this Third Assignment Agreement to (i) clarify and expand the scope of Licensors entitlement to royalties and the term thereof, (ii) provide for Licensee to advance additional funds to assist Licensor in paying outstanding and future obligations prior to the receipt by Licensee of Net Sales from Products, and (iii) further amend the timing of the payment obligations in light of the available cash flow and cash flow needs of the parties; and that the modifications made in this Third Assignment Agreement to the Second Amended and Restated Assignment Agreement are in the best interests of each of the parties hereto.
License Property
Product or Products means any product (or use thereof) that is covered by at least one valid and enforceable claim of the Patents that relates to anesthetizing a portion or all of a patient’s maxillary dental arch using a nasally delivered anesthetizing composition.

Patents means (1) U.S. Patent No. 6,413,499 and all inventions disclosed and claimed therein, all foreign patents and applications, and all substitutes, reissues, reexaminations, extensions, renewals, reinstatements and restorations of any of the foregoing, and (2) any additional patent claims approved in the United States or any foreign jurisdiction relating to anesthetizing a portion or all of a patient’s maxillary dental arch using a nasally delivered anesthetizing composition, including certain of such claims in U.S. Patent No. 8,580,282 issued on November 12, 2013 to Mark David Kollar for a Dental Anesthetic Comprising Tetracaine and a Vasoconstrictor for Intranasal Administration (which patent was the subject of a provisional application filed on April 3, 2009).

U.S. Patent No. 6,413,499 – Methods and kits for maxillary dental anesthesia by means of a nasal deliverable anesthetic

U.S. Patent No. 8,580,282 – Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration

Field of Use
This agreement pertains to the drug industry relating to dental anesthesia.

IPSCIO Record ID: 254416

License Grant
Licensor, a subsidiary, entered into an agreement with Licensee transfer the 499 Patent and related intellectual property
License Property
The 499 Patent and related intellectual property is related to Products that involve anesthetizing a portion or all of a patient’s maxillary dental arch using a nasally delivered anesthetizing composition.  6,413,499: Methods and kits for maxillary dental anesthesia by means of a nasal deliverable anesthetic
Field of Use
The present invention relates to methods and systems for anesthetizing a patient's teeth and surrounding palatal tissues within the maxillary dental arch by means of a nasal deliverable anaesthetic. Such methods and systems eliminate altogether the need for painful needle injected local anesthetics when preparing a patient for dental work on the maxillary, or upper, dental arch. By this means, patients will have less fear and anxiety when visiting a dentist and will experience greatly decreased pain associated with the application of the local anesthetic preparatory to carrying out the actual dental procedure.

IPSCIO Record ID: 248285

License Grant
The Norwegian Licensor hereby grants Licensee an exclusive (even as to Licensor) license to and under the Licensor Know-How, the Licensor Patents, the Licensor Trademarks and the Licensor Additional Intellectual Property: (i) to use, sell, offer for sale, have sold and import the Product in the Licensed Territory; and (ii) to make or have made the Product anywhere in the world solely for such permitted use, sale, offer for sale and importation in the Licensed Territory.
License Property
Device means a nasal device used for the delivery of pharmaceutical products in a powder or liquid formulation and that is covered by an Licensor Patent listed below.

6,715,485 – Nasal delivery device
8,327,844 – Nasal delivery method
7,740,014 – Nasal devices

Product(s) means any products or product candidates developed by or under the authority of a Party or any of its Affiliates as of the Effective Date or during the Term consisting of a formulation that contains [as its sole active ingredient] a compound within the class of compounds [known as triptans], including any salt, polymorphic or amorphous form of such a compound, that is delivered in a nasal delivery device; [provided that, the foregoing definition of Product may be amended and expanded by the mutual agreement of the Parties, in each Partys sole discretion, to include a formulation of triptan with one or more other active ingredients]. For purposes of the foregoing, the class of compounds known as [triptans] includes the compounds known as of the Effective Date as the following: Sumatriptan[, rizatriptan, naratriptan, zolmitriptan, almotriptan, frovatriptan, avitriptan and eletriptan]. Solely for the purposes of a Product shall also include products or product candidates consisting of [ a formulation that contains a compound within the class of compounds known as triptans (including any salt, polymorphic or amorphous form of such a compound) together with one or more other active ingredients, that is delivered in a nasal delivery device].  

Licensor Patent means, all Patents Controlled by, Licensor or any of its Affiliates as of the Effective Date or during the Term that cover or claim a Product and/or Device, including those Patents listed, together with all divisionals, substitutions, registrations, re-examinations, additions, continuations, continuations in-part, reissues, renewals and Patent Term Extensions of or to any of the foregoing. For clarity,

Licensor Patents shall include any Patents Controlled by Licensor or any of its Affiliates that cover or claim a Device Improvement.

Licensor Trademarks means, any, whether domestic or foreign, trademarks, service marks, and trade names Controlled by Licensor or any of its Affiliates as of the Effective Date or during the Term that are used (or required to be used) in connection with the Device or a Product in the Licensed Territory, including those trademarks, service marks and trade names listed (the 'Existing Licensor Trademarks').  
Service marks and trade names:
Optimist, Optimose, Breath Powered, Bi-Directional

Licensor IP means, collectively, the Licensor Patents, Licensor Know-How, Licensor Trademarks, and Licensor Additional Intellectual Property.

Licensor Additional Intellectual Property means, any industrial designs, works of authorship, and copyrights Controlled by Licensor or any of its Affiliates as of the Effective Date or during the Term that are necessary or reasonably useful for the research, development, use, manufacture, sale or other commercialization of the Product or Device.

Field of Use
The rights granted apply to the healthcare industry relating to pharmaceutical products.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.